Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.
about
Targeting T cells to treat atherosclerosis: odyssey from bench to bedsideRole of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisToll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosisImmune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis.IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosisProinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice.Toll-like receptor 2 activation and serum amyloid A regulate smooth muscle cell extracellular matrix.Toll-like Receptors in the Vascular System: Sensing the Dangers Within.Low TLR7 gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular events.Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress.Ginkgolide B Suppresses TLR4-Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose-Treated HUVECs.Relation between TLR4/NF-κB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability.Hypoxia in Atherogenesis.miR-195 inhibits macrophages pro-inflammatory profile and impacts the crosstalk with smooth muscle cells.LC3-Associated Phagocytosis and Inflammation.Endothelial Jag1-RBPJ signalling promotes inflammatory leucocyte recruitment and atherosclerosis.Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses.
P2860
Q26740179-9E381C9A-F130-4758-8A3F-55B01459038CQ26777991-50C82EEE-008E-434E-AEE9-F86AAA8246CDQ33678336-3DE057F6-B82C-49F0-B17C-61E8ED36210AQ34510105-0C80568F-84A1-4943-8DFA-97D8C742DA9BQ35070231-58C9206E-F7A6-4240-84F3-BE1757D37547Q35889971-3513DCD5-508E-4288-9C62-A5514807A4F0Q36296737-61E2B00E-2D45-4C04-8A38-1EBCF3475CBBQ36453194-CA318862-54BB-4EE1-87F1-FF78D621A9B0Q37572208-0AC36BCE-DAE1-4F27-AC08-2B357D16EB83Q37736555-3570BB15-3A8B-4514-8C6A-14B5A26BD6EDQ38635852-73163965-C122-4EB5-A62A-0D513FD5CDBEQ38901560-C153DDD4-EF4C-4DC6-BAD5-BA727E599EA1Q38939115-3E4405C1-9661-4AFF-8FF9-FD7B6F64C7E9Q47093765-BDB4063F-E3A2-4126-922F-7163D9F6CD66Q47895048-70BCCAD4-AE4B-4CB5-9AD2-83AF00DE6D86Q49133799-B829B298-C978-4AFB-A617-A290678F496BQ55099798-A88B1FD6-831B-49D1-AFAD-8ACD0283F864
P2860
Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.
@en
type
label
Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.
@en
prefLabel
Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.
@en
P1476
Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.
@en
P2093
Christina Kassiteridi
P304
P356
10.1016/J.TIPS.2013.09.008
P577
2013-10-15T00:00:00Z